S. Saglani (London, United Kingdom), M. Kabesch (Regensburg, Germany)
Biologicals in the treatment of severe asthma in children: A PERMEABLE assessment of the current practice in Europe
M. Kabesch (Regensburg, Germany), H. Buntrock-Döpcke (Regensburg, Germany), J. Niggel (Regensburg, Germany), K. Golebski (Amsterdam, Netherlands), C. Van Drunen (Amsterdam, Netherlands), S. Reinarts (Hilversum/Blaricum, Netherlands), U. Potocnik (Maribor, Slovenia), E. Melén (Stockholm, Sweden), A. Maitland-Van Der Zee (Amsterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands)
|  |
Respiratory modulation of the pulse oximeter plethysmogram amplitude as a marker of severity in acutely wheezy young children
D. Wertheim (Kingston, United Kingdom), O. Anton (Brighton, United Kingdom), C. Olden (Brighton, United Kingdom), P. Seddon (Brighton, United Kingdom)
|  |
Identifying T-lymphocytes in the sputum of children with acute asthma
M. Philpot (Leicester, United Kingdom), D. Cousins (Leicester, United Kingdom), E. Gaillard (Leicester, United Kingdom)
| |
Effect of nasal polivalent bacterial lysate on the clinical course of seasonal allergic rhinitis in children - preliminary study.
M. Kowalska (Lublin, Poland), A. Emeryk (Lublin, Poland), K. Janeczek (Lublin, Poland), I. Czerwinska Pawluk (Lublin, Poland)
| |
Elevated type I collagen degradation predicts persistent asthma in children
S. Rønnow (Herlev, Denmark), B. Hoffmann-Petersen (Odense, Denmark), J. Marie Bülow Sand (Herlev, Denmark), M. Karsdal (Herlev, Denmark), H. Marlies Rasmussen (Odense, Denmark), L. Agertoft (Odense, Denmark), D. Julie Leeming (Herlev, Denmark), G. Lykke Sørensen (Odense, Denmark)
| |
Metabolomics applied to exhaled breath condensate in asthmatic children treated with inhaled steroids
V. Ferraro (Padua, Italy), S. Carraro (Padova, Italy), P. Pirillo (Padova, Italy), G. Poloniato (Padova, Italy), M. Stocchero (Padova, Italy), G. Giordano (Padova, Italy), S. Zanconato (Padova, Italy), E. Baraldi (Padova, Italy)
| |
Prescribing patterns of antiasthma medication in children and adolescents in primary care in France.
I. Naiim (Paris, France), V. Houdouin (Paris, France), A. Ajrouche (Paris, France), F. Tubach (Paris, France), S. Guillo (Paris, France), Y. De Rycke (Paris, France), F. Kaguelidou (Paris, France)
| |
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
B. Davies (Birmingham, United Kingdom), S. Frost (Birmingham, United Kingdom), S. Rao (Birmingham, United Kingdom), D. Thickett (Birmingham, United Kingdom), S. Saglani (London, United Kingdom), P. Nagakumar (Birmingham, United Kingdom)
| |
Identification of disease-specific molecular breath profiles in patients with allergic asthma
R. Weber (Zurich, Switzerland), S. Micic (Zurich, Switzerland), B. Streckenbach (Zurich, Switzerland), L. Welti (Zurich, Switzerland), T. Bruderer (Zurich, Switzerland), N. Perkins (Zurich, Switzerland), D. Inci (Zurich, Switzerland), J. Usemann (Zurich, Switzerland), A. Möller (Zurich, Switzerland)
| |
Familial co-aggregation of asthma and type 1 diabetes mellitus in children– a Swedish population-based cohort study
A. Smew (Stockholm, Sweden), C. Lundholm (Stockholm, Sweden), L. Sävendahl (Stockholm, Sweden), P. Lichtenstein (Stockholm, Sweden), C. Almqvist (Stockholm, Sweden)
| |
Cord blood Interleukin-13 and IFN-Gamma levels As Biomarkers of Ever-Wheezing in the First Year of Life
Ö. Yilmaz (Manisa, Turkey), A. Yasar (Manisa, Turkey), P. Ay (Istanbul, Turkey), A. Çaliskan Polat (Manisa, Turkey), F. Odabasi Cingöz (Manisa, Turkey), T. Alkin (Izmmir, Turkey), F. Taneli (MManisa, Turkey), S. Hasdemir (MManisa, Turkey), Y. Simsek Basbay (MManisa, Turkey), H. Yüksel (MManisa, Turkey)
| |
Functional status of ciliated epithelium in children with mild, moderate, and severe asthma
I. Ozerskaia (Moscow, Russian Federation), N. Geppe (Moscow, Russian Federation), U. Malyavina (Moscow, Russian Federation)
| |
Associations of serum cytokine levels with asthma, wheeze and allergic rhinitis symptoms in 5-years old children: a population-based study
I. Annesi Maesano (Paris, France), G. Pesce ((Indiquez au préalable le code postal), France), N. Glaichenhaus (Valbonne, France)
| |
Changes in nitric oxide (NO) cycle metabolites in children with mild asthma (BA) receiving STEP-2 therapy
M. Glukhova (Moscow, Russian Federation), N. Geppe (Moscow, Russian Federation), S. Soodaeva (Moscow, Russian Federation), I. Klimanov (Moscow, Russian Federation), N. Kolosova (Moscow, Russian Federation)
| |
The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression
I. Ricklefs (Luebeck, Germany), L. Schäfer (Luebeck, Germany), N. Weissheimer (Luebeck, Germany), M. Weckmann (Luebeck, Germany), D. Thiele (Luebeck, Germany), I. König (Luebeck, Germany), E. Von Mutius (Munich, Germany), G. Hansen (Hanover, Germany), K. Rabe (Großhansdorf, Germany), M. Kopp (Luebeck, Germany)
| |